We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: news

Optimizing Nurse-Led Smoking Cessation: Insights from a Systematic Review and Network Meta-Analysis

MedXY Editorial Team•Oct 12, 2025•news
Network meta-analysisNurse-led interventionssmoking cessationVarenicline

Highlight

  • Intensive counseling combined with varenicline or family-based interventions significantly improves smoking cessation rates compared to brief advice or usual care.
  • Brief advice and brief counseling led by nurses outperform usual care, underlining the importance of routine nurse involvement in tobacco cessation efforts.
  • The certainty of evidence for the most effective nurse-led interventions ranges from low to moderate, highlighting the need for more high-quality randomized trials.
  • Nurse-led smoking cessation strategies are essential and scalable approaches to enhance tobacco abstinence within and beyond six months.

Study Background

Tobacco use remains a persistent global health challenge, substantially reducing quality of life and life expectancy across all patient populations. Smoking cessation is paramount in reducing tobacco-related morbidity and mortality. Nurses, who represent the largest workforce of healthcare professionals worldwide, are uniquely positioned to deliver smoking cessation interventions due to their frequent patient contact and trusted role in health promotion.

Despite the known effectiveness of nurse-led interventions, there is variability in the types and intensities of these approaches, and a lack of consensus on the optimal strategy to support smoking patients. This study addresses this gap by systematically evaluating and comparing multiple nurse-led smoking cessation interventions using a robust network meta-analysis framework.

Study Design

This systematic review and network meta-analysis included randomized controlled trials (RCTs) that enrolled smoking patients receiving nurse-led smoking cessation interventions. Comprehensive literature searches were performed in PubMed, Web of Science, CINAHL, Embase, PsycINFO, Scopus, and the Cochrane Central Register of Controlled Trials from inception to May 10, 2025.

Eligible studies were those reporting on the effectiveness of nurse-led interventions, with the primary outcome defined as the prevalence of tobacco abstinence at the last follow-up, measured either by self-report or biochemically validated methods. Secondary outcomes examined abstinence rates within six months and beyond six months.

Intervention strategies identified included brief advice, brief counseling, intensive counseling alone, and intensive counseling combined with pharmacological treatments such as varenicline or nicotine replacement therapy (NRT), as well as family-based interventions. The revised Cochrane risk-of-bias tool assessed study quality, and CINeMA software analyzed evidence credibility. Risk ratios (RR) with 95% confidence intervals were calculated using random-effects network meta-analysis models.

Key Findings

From an initial 3512 identified records, 26 RCTs involving 14,367 smoking patients met inclusion criteria. Eight nurse-led intervention combinations were compared.

The network meta-analysis demonstrated the following relative effectiveness compared to brief advice:

  • Intensive counseling + varenicline: RR 2.78 (95% CI 1.95–3.95), moderate certainty.
  • Intensive counseling + family-based intervention: RR 2.68 (95% CI 1.63–4.39), moderate certainty.
  • Intensive counseling + nicotine replacement therapy: RR 1.38 (95% CI 1.08–1.77), low certainty.
  • Intensive counseling alone: RR 1.17 (95% CI 1.01–1.36), very low certainty.

Additionally, brief advice (RR 1.51, 95% CI 1.12–2.02) and brief counseling (RR 1.54, 95% CI 1.13–2.09) were superior to usual care, though supported by low certainty evidence.

The surface under the cumulative ranking curve (SUCRA) identified intensive counseling combined with varenicline and intensive counseling with family-based intervention as the top-ranked interventions for increasing tobacco abstinence prevalence within and beyond six months, with probabilities of 99.6% and 99.7%, respectively.

This indicates that integrating pharmacological support or leveraging family involvement alongside intensive counseling substantially boosts smoking cessation success.

Expert Commentary

The findings reinforce the critical role of nurses in smoking cessation, highlighting that even brief interactions involving advice or counseling can surpass usual care and contribute positively to tobacco abstinence.

While the added value of intensive counseling combined with varenicline or family support is notable, the moderate to low certainty of evidence suggests cautious interpretation. Variability in study design, intervention fidelity, and measurement methods contribute to this uncertainty.

Clinical guidelines increasingly advocate for personalized interventions that combine behavioral and pharmacological strategies to optimize smoking cessation outcomes. Nurses, given their extended and trusted patient relationships, are ideally positioned to deliver such multifaceted interventions effectively.

Future high-quality RCTs with standardized outcome assessments and longer follow-up are needed to strengthen evidence, especially concerning family-based support mechanisms and combinations with nicotine replacement therapies.

Conclusion

Nurse-led smoking cessation interventions demonstrate clear benefits for patients who smoke, with simple brief advice or counseling already improving quitting rates compared to usual care.

More intensive nurse-led counseling combined with varenicline or family-based interventions offers the greatest efficacy in supporting tobacco abstinence, sustaining success both in the short and long term.

Healthcare systems and clinical practice should prioritize training and resources to enable nurses to deliver these effective, evidence-based interventions. Enhanced support for robust research is also warranted to further refine optimal strategies and increase the certainty of evidence guiding clinical decisions.

Funding and Registration

The study protocol was registered at PROSPERO under registration number CRD42023479985. Funding sources were not detailed in the original publication.

References

Zhang G, Zhou J, Xu Y, Ding H, Luk TT, He AW, Wang MP, Chan SSC, Cheung YTD. Effectiveness of nurse-led smoking cessation interventions in smoking patients: A systematic review and network meta-analysis of randomized controlled trials. Int J Nurs Stud. 2025 Nov;171:105201. doi: 10.1016/j.ijnurstu.2025.105201. Epub 2025 Aug 27. PMID: 40907094.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Lifelong Risk of De Novo Aneurysm Formation in Young Survivors of Aneurysmal Subarachnoid Hemorrhage: A Four-Decade PerspectiveYoung survivors of aneurysmal subarachnoid hemorrhage face a lifelong risk of developing new aneurysms, with female sex, smoking, and family history as key risk factors. Smoking cessation reduces this risk, supporting need for lifelong survAug 25, 2026Optimizing Smoking Cessation Interventions in Lung Cancer Screening: Insights from the CASTL TrialThe CASTL trial evaluated efficient combinations of tobacco cessation interventions for smokers undergoing lung cancer screening, identifying loss-framed messaging with nicotine replacement therapy as the most cost-effective strategy.Jul 11, 2026Embedding Tobacco Treatment Into Cancer Care Achieved Universal Screening but Exposed Persistent Gaps in Cessation AssistanceA cancer program quality improvement initiative reached a 100% smoking-status ask rate through an electronic hard stop, but assistance for identified smokers remained inconsistent, underscoring the implementation gap between screening and eMay 29, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Varenicline and Ventricular Ectopy After Myocardial Infarction: A Randomized Phase 2 Study
This phase 2 trial demonstrates that varenicline, a partial nAChR agonist, significantly reduces premature ventricular complexes and nonsustained ventricular tachycardia in post-myocardial infarction patients, offering a novel therapeutic t
Mar 9, 2026
Beyond Dopamine Blocking: Network Meta-Analysis Redefines Efficacy and Tolerability Hierarchies in Acute SchizophreniaA landmark network meta- **Developing Article Components** I’m now diving deep into the content, focusing on fleshing out each section. The Highlight section’s first drafts are complete. I’m incorporating the study’sMar 6, 2026
Beyond the Initial Quit: Mobile Chat Messaging as a Scalable Solution for Smoking Relapse PreventionRecent clinical trials demonstrate that mobile chat-based interventions, combining live counselors and chatbots, significantly reduce smoking relapse rates and improve long-term abstinence through personalized, real-time support and engagemJan 26, 2026